Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccinationP Van Damme, P Beutels
Acta Clinica Belgica|March 1, 2006
Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the resultsN Thiry, P Beutels, P Van Damme
Vaccine|January 1, 1995
Hepatitis B prevention in Europe: a preliminary economic evaluationP Van Damme, G Tormans, P Beutels, et al.
The Journal of Infection|July 25, 2000
The disease burden of hepatitis B in UzbekistanP Beutels, E I Musabaev, P Van Damme, et al.
Aviation, Space, and Environmental Medicine|February 1, 1996
Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccinationT Gutersohn, R Steffen, P Van Damme, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 28, 2009
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008C Simoens, M Sabbe, P Van Damme, et al.
Epidemiology and Infection|May 22, 2013
Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementationH Theeten, V Hutse, K Hoppenbrouwers, et al.
The Journal of Infectious Diseases|November 1, 1996
Costs and benefits of routine varicella vaccination in German childrenP Beutels, R Clara, G Tormans, et al.
Epidemiology and Infection|May 10, 2008
Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virusT Van Effelterre, Z Shkedy, M Aerts, et al.
Pageof 23